To mitigate the risk of nocturnal hypoglycaemia, it is therefore typically recommended to reduce the dose of first-generation long-acting insulin at bedtime or the basal rate of insulin infusion in pump users by 20% after afternoon or evening exercise [3]. This evidence concerns the gene INS and Hypoglycemia.